Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercial-ize Anti-IL17A
Shandong Fontacea An...
Dec 17, 2019 -- Fontacea announced today that it has entered into an exclusive license, development and commercialization agreement with Janssen to develop and commercialize pharmaceutical
History
History
July, 2019, Shandong Fontacea Pharmaceutical Institude Co. Ltd (“Institute”) was founded; April, 2019, Fontacea established Shandong Fontacea Pharmaceutical Co., Ltd.
Enterprise style
pipeline
 pipeline2019-12-16
暂无信息!
暂无信息!